Fulcrum Therapeutics Inc. (NASDAQ: FULC) reported Q3 EPS of ($0.35), $0.05 better than the analyst estimate of ($0.40).

For earnings history and earnings-related data on Fulcrum Therapeutics Inc. (FULC) click here.